• 1
    Zimmet, P., Thomas, C. R. (2003) Genotype, obesity and cardiovascular disease—has technical and social advancement outstripped evolution? J Intern Med. 254: 114125.
  • 2
    Rashid, M. N., Fuentes, F., Touchon, R. C., Wehner, P. S. (2003) Obesity and the risk for cardiovascular disease. Prev Cardiol. 6: 4247.
  • 3
    Cummings, D. E., Schwartz, M. W. (2003) Genetics and pathophysiology of human obesity. Annu Rev Med. 54: 453471.
  • 4
    Schwartz, M. W. (2001) Brain pathways controlling food intake and body weight. Exp Biol Med. 226: 978981.
  • 5
    Mora, S., Pessin, J. E. (2002) An adipocentric view of signaling and intracellular trafficking. Diabetes Metab Res Rev. 18: 345356.
  • 6
    Cottam, D. R., Schaefer, P. A., Shaftan, G. W., Velcu, L., Angus, L. D. (2002) Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg. 12: 335342.
  • 7
    Das, U. N. (2001) Is obesity an inflammatory condition? Nutrition. 7: 953966.
  • 8
    Lyon, C. J., Law, R. E., Hsueh, W. A. (2003) Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 144: 21952200.
  • 9
    Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., Lodish, H. F. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 270: 2674626749.
  • 10
    Ouchi, N., Kihara, S., Arita, Y., et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 100: 24732476.
  • 11
    Ouchi, N., Ohishi, M., Kihara, S., et al. (2003) Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 42: 231234.
  • 12
    Steppan, C. M., Bailey, S. T., Bhat, S., et al. (2001) The hormone resistin links obesity to diabetes. Nature. 409: 307312.
  • 13
    Holcomb, I. N., Kabakoff, R. C., Chan, B., et al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19: 40464055.
  • 14
    Nagaev, I., Smith, U. (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 285: 561564.
  • 15
    Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., Sharma, A. M. (2002) Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res. 10: 15.
  • 16
    Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402: 656660.
  • 17
    Wren, A. M., Seal, L. J., Cohen, M. A., et al. (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 86: 5992
  • 18
    Tschop, M., Smiley, D. L., Heiman, M. L. (2000) Ghrelin induces adiposity in rodents. Nature. 407: 908913.
  • 19
    Faraj, M., Havel, P. J., Phelis, S., Blank, D., Sniderman, A. D., Cianflone, K. (2003) J. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 88: 15941602.
  • 20
    Guldstrand, M., Ahren, B., Adamson, U. (2003) Improved beta-cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab. 284: E557E565.
  • 21
    Cummings, D. E., Weigle, D. S., Frayo, R. S., et al. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 346: 16231630.
  • 22
    Holdstock, C., Engstrom, B. E., Ohrvall, M., Lind, L., Sundbom, M., Karlsson, F. A. (2003) Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 88: 31773183.
  • 23
    Capella, R. F., Capella, J. F. (1997) Reducing early technical complications in gastric bypass surgery. Obes Surg. 7: 149157.
  • 24
    Buchwald, H., Buchwald, J. N. (2002) Evolution of operative procedures for the management of morbid obesity 1950-2000. Obes Surg. 12: 705717.
  • 25
    Lukaski, H. C., Bolonchuk, W. W., Hall, C. B., Siders, W. A. (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 60: 13271332.
  • 26
    World Health Organization. (1997) Obesity: preventing and managing the global epidemic. Report on a WHO Consultation on Obesity: WHO/NUT/NCD/98.1. World Health Organization: Geneva, Switzerland.
  • 27
    Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28: 412419.
  • 28
    Friedewald, W. T., Levi, R. I., Fredrickson, D. S. (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem. 18: 499502.
  • 29
    Chu, N. F., Spiegelman, D., Rifai, N., Hotamisligil, G. S., Rimm, E. B. (2000) Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord. 24: 10851092.
  • 30
    Mantzoros, C. S., Moschos, S., Avramopoulos, I., et al. (1997) Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab. 82: 34083413.
  • 31
    Zhang, H. H., Kumar, S., Barnett, A. H., Eggo, M. C. (2000) Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol. 159: 7978.
  • 32
    Yamaguchi, M., Murakami, T., Tomimatsu, T., et al. (1998) Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro. Biochem Biophys Res Commun. 244: 3034.
  • 33
    Corica, F., Allegra, A., Corsonello, A., et al. (1999) Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Int J Obes Relat Metab Disord. 23: 355360.
  • 34
    Bullo, M., Garcia-Lorda, P., Salas-Salvado, J. (2002) Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. Eur J Endocrinol. 146: 325331.
  • 35
    Finck, B. N., Johnson, R. W. (2000) Tumor necrosis factor (TNF)-alpha induces leptin production through the p55 TNF receptor. J Physiol Regul Integr Comp Physiol. 278: R537R543.
  • 36
    Molina, A., Vendrell, J., Gutierrez, C., et al. (2003) Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Obes Surg. 13: 615621.
  • 37
    Maeda, N., Takahashi, M., Funahashi, T., et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 50: 20942099.
  • 38
    Bruun, J. M., Lihn, A. S., Verdich, C., et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 285: E527E533.
  • 39
    Ouchi, N., Kihara, S., Arita, Y., et al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 102: 12961301.
  • 40
    Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., Ranganathan, G. (2003) Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 52: 17791785.
  • 41
    Gustafson, B., Jack, M. M., Cushman, S. W., Smith, U. (2003) Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Biochem Biophys Res Commun. 308: 933939.
  • 42
    Hansen, T. K., Dall, R., Hosoda, H., et al. (2002) Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol. 56: 203206.
  • 43
    Adami, G. F., Cordera, R., Marinari, G., Lamerini, G., Andraghetti, G., Scopinaro, N. (2003) Plasma ghrelin concentration in the short-term following biliopancreatic diversion. Obes Surg. 13: 889892.
  • 44
    Tritos, N. A., Mun, E., Bertkau, A., Grayson, R., Maratos-Flier, E., Goldfine, A. (2003) Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res. 11: 919924.
  • 45
    Leonetti, F., Silecchia, G., Lacobellis, G., et al. (2003) Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab. 88: 42274231.
  • 46
    Ott, V., Fasshauer, M., Dalski, A., et al. (2002) Direct peripheral effects of ghrelin include suppression of adiponectin expression. Horm Metab Res. 34: 640645.
  • 47
    Nagaya, N., Uematsu, M., Kojima, M., et al. (2001) Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 104: 20342038.
  • 48
    Beltowski, J. (2003) Adiponectin and resistin—new hormones of white adipose tissue. Med Sci Monit. 9: RA55RA61.
  • 49
    Shojima, N., Sakoda, H., Ogihara, T., et al. (2002) Humoral regulation of resistin expression in 3T3–L1 and mouse adipose cells. Diabetes. 51: 17371744.
  • 50
    Kaser, S., Kaser, A., Sandhofer, A., Ebenbichler, C. F., Tilg, H., Patsch, J. R. (2003) Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 309: 286290.
  • 51
    Savage, D. B., Sewter, C. P., Klenk, E. S., et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 50: 21992202.
  • 52
    Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E., et al. (2003) Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 88: 54525455.
  • 53
    Youn, B. S., Yu, K. Y., Park, H. J., et al. (2004) Plasma resistin concentration measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 89: 150156.
  • 54
    Fujinami, A., Obayashi, H., Ohta, K., et al. (2004) Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta. 339: 5763.
  • 55
    Pfutzner, A., Langenfeld, M., Kunt, T., Lobig, M., Forst, T. (2003) Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab. 49: 571576.
  • 56
    Lee, J. H., Chan, J. L., Yiannakouris, N., et al. (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting leptin administration: cross-sectional and interventional study in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 88: 48484856.
  • 57
    Yang, J., Li, M., Wu, C. Y., Wang, H., Xu, Q. S., Deng, J. Y. (2003) Reduced resistin levels in patients with type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi. 83: 14711474.